ARCHIVES

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

This article is from The Cancer Letter archive.

Vol. 23 No. 48 | December 19, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Lists Projected Grant Paylines

February 16, 1996

DCT Issues Two Pas for Small/Exploratory Grants For Clinical, Laboratory Studies

March 23, 1994

Waxman urges drug companies to list clinical trials on NIH Web site.

June 18, 2004

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979